BIOMAT Database Logo BIOMAT Database Logo

Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. 1998

Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Diabetes Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.

The pathways involved in the cellular responses to the insulin-like growth factors (IGFs) are numerous and vary according to cell type. Following activation of the IGF-I receptor, the mitogen-activated protein kinase and phosphatidylinositide 3'-kinase (PI3'K) pathways are activated and result in cellular proliferation and inhibition of apoptosis. In this study, we analyzed the IGF-I effect on the stress-activated protein kinase/c-Jun N-terminal kinase (JNK) activity using human embryonic kidney 293 cells, 293 cells transiently expressing hemagglutinin-JNK, and 293 cells stably expressing a hemagglutinin-JNK transgene. In all cell types, endogenous or transfected JNK activity was strongly stimulated by anisomycin or tumor necrosis factor-alpha, and 10 nM IGF-I pretreatment suppressed the induced JNK activity. To determine whether the effect of IGF-I on JNK activity involves the mitogen-activated protein kinase or PI3'K pathway, we used the specific MEK1 inhibitor PD098059 and the PI3'K inhibitor LY 294002. PD098059 did not alter the IGF-I suppressive effect on stressor-induced JNK activity, but LY 294002 suppressed the IGF-I effect. Moreover, in transiently transfected parental 293 cells expressing dominant-negative Akt, anisomycin-increased JNK activity was not suppressed by pretreatment with IGF-I. Our results demonstrate that the action of IGF-I on JNK in these cells is via PI3'K and Akt.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000081082 Phosphoinositide-3 Kinase Inhibitors Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity. Phosphoinositide-3 Kinase Inhibitor,Inhibitor, Phosphoinositide-3 Kinase,Inhibitors, Phosphoinositide-3 Kinase,Kinase Inhibitor, Phosphoinositide-3,Kinase Inhibitors, Phosphoinositide-3,Phosphoinositide 3 Kinase Inhibitor,Phosphoinositide 3 Kinase Inhibitors

Related Publications

Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I.
June 1998, The Journal of biological chemistry,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein.
April 1997, Journal of neurochemistry,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells.
July 2004, Endocrinology,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase.
November 1997, Biochemistry,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells.
February 2000, Endocrinology,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Regulation and functions of c-Jun N-terminal kinase/stress-activated protein kinase.
February 2000, Chang Gung medical journal,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Rb protein down-regulates the stress-activated signals through inhibiting c-Jun N-terminal kinase/stress-activated protein kinase.
May 2000, The Journal of biological chemistry,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.
April 1997, Proceedings of the National Academy of Sciences of the United States of America,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism.
January 2000, The Journal of biological chemistry,
Y Okubo, and V A Blakesley, and B Stannard, and S Gutkind, and D Le Roith
TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase.
March 1997, The Journal of biological chemistry,
Copied contents to your clipboard!